Skip to content

Neritam

A Changing World of Many Answers

  • Home
  • നേരിടം
  • Opinion
  • Contact

Corporate

Posted inUncategorized

American CEOs make 351 times more than workers. In 1965 it was 15 to one

by editorSeptember 6, 20210

Last week, the Economic Policy Institute, a nonpartisan thinktank, released a report on the increasing pay gap between chief executives and workers. This research tells … American CEOs make 351 times more than workers. In 1965 it was 15 to oneRead more

Posted inUncategorized

Sacklers Threaten to Pull Out of Opioid Settlement

by editorSeptember 2, 20210

A scion of the Sackler family, the billionaire owners of Purdue Pharma, vowed in court on Tuesday that the family would walk away from a … Sacklers Threaten to Pull Out of Opioid SettlementRead more

Posted inUncategorized

Big Pharma Firms Spent More Enriching Investors Than on R&D

by editorAugust 31, 20210

The leading 14 Big Pharma firms paid out more to enrich their investors than they spent on research and development from 2016 to 2020, a … Big Pharma Firms Spent More Enriching Investors Than on R&DRead more

Posted inUncategorized

Pfizer must Share COVID Vaccine Technology with Africa

by editorAugust 30, 20210

The Food and Drug Administration has fully authorized the Pfizer-BioNTech COVID-19 vaccine for U.S. residents aged 16 and over, making it the first COVID vaccine … Pfizer must Share COVID Vaccine Technology with AfricaRead more

Posted inUncategorized

Fast fashion is now poisoning African rivers

by editorAugust 28, 20210

Rivers in some African countries are turning the colour of ink, and fast fashion is behind it. Untreated or partially treated effluent from textile factories, … Fast fashion is now poisoning African riversRead more

Posted inUncategorized

OxyContin maker Purdue Pharma pleads guilty to criminal charges

by editorAugust 25, 20210

Purdue Pharma LP pleaded guilty to criminal charges over the handling of its addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve … OxyContin maker Purdue Pharma pleads guilty to criminal chargesRead more

Posted inUncategorized

The Corporate Top 1% Control Over 50% of International Trade

by editorAugust 24, 20210

[youtube https://www.youtube.com/watch?v=DdPhlGNV_to&rel=0&feature=relmfu] Richard Kozul-Wright

Posted inUncategorized

Vaccine monopolies make cost of vaccinating the world against COVID at least 5 times

by editorAugust 23, 20210

The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren’t profiteering from their monopolies on COVID-19 … Vaccine monopolies make cost of vaccinating the world against COVID at least 5 timesRead more

Posted inUncategorized

Pandemic profiteers

by editorAugust 22, 20210

Faced with an economic crisis that could lead to starvation or riots, a finance minister was forced to default on their country’s debt, massively devalue … Pandemic profiteersRead more

Posted inUncategorized

Billionaires Backed Consortium To Buy U.K. Maker Of Covid Tests For $41 Million

by editorAugust 18, 20210

Billionaires George Soros and Bill Gates are part of a consortium set to buy Mologic, a U.K.-based maker of Covid tests, in an effort to … Billionaires Backed Consortium To Buy U.K. Maker Of Covid Tests For $41 MillionRead more

Posts navigation

Previous 1 … 16 17 18 … 116 Next

Recent Posts

  • Facebook ‘Bot’ Adviser Secretly in Pay of US Regime Change Agency
  • Stop! Grand theft water
  • Forest emissions: A chiral surprise in the rainforest
  • What is FreeTube?
  • Freedom vs. Compelled Birth

Recent Comments

  • Frans W on 14 eyebrow-raising personal details Google knows about you
  • Rob Alberts on Apple doesn’t want you to be able to fix your own phone
  • Ron Pennington on US ‘Has the Gall’ to Ask Cambodia to Pay War Debt
  • Rob Alberts on How rich people get money
  • Rob Alberts on What Happens if You’re Too Poor to Pay Bail?

Archives

Categories

Copyright © 2025 Neritam.
Powered by WordPress and BNM.
  • Home
  • നേരിടം
  • Opinion
  • Contact